Biocon to file for Syngene's IPO in two months: Reports

The initial public offering (IPO) could fetch up to Rs 1,000 crore ($159.8 million), according to reports


Biocon now owns an 85.54 percent stake in Syngene

Biotechnology major Biocon could file a prospectus for a share listing for its research services business arm Syngene International within the next two months, says reports.

Earlier this year, Biocon has said that it is looking to sell 10-15 percent stock from its majority stake in Syngene via an offer for sale. The company now owns an 85.54 percent stake in Syngene. 

Reportedly, The IPO for Syngene will be managed by Credit Suisse, Axis Bank and Jefferies.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email